My Dashboard
Fin. Planning
Our Solutions
Stocks
Funds
Invest in the best stock opportunities right now and every time.
Start Research-backed Investing ...in less than a minute.
BSE: 531207 | NSE: | Pharmaceuticals & Drugs | Small Cap
1. Is Raymed Labs Ltd a good quality company?
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Raymed Labs Ltd is a below average quality company.
2. Is Raymed Labs Ltd undervalued or overvalued?
The key valuation ratios of Raymed Labs Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
3. Is Raymed Labs Ltd a good buy now?
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Raymed Labs Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘValue Creation Index Colour Code Guide ⓘ |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | TTM | |||
| ROCE % ⓘ | -9.8% | -6.5% | -7.1% | -9% | -17.9% | -26.7% | -35.9% | -105.5% | -94.4% | 8.1% | - | ||
| Value Creation Index ⓘ | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | - | ||
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ |
|||||||||||||
| Sales ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| YoY Gr. Rt. % | - | NA | NA | NA | NA | NA | NA | NA | NA | NA | - | ||
| Adj EPS ⓘ | -0.1 | -0.1 | -0 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.2 | -0.2 | -0.3 | ||
| YoY Gr. Rt. % | - | NA | NA | NA | NA | NA | NA | NA | NA | NA | - | ||
| BVPS (₹) ⓘ | -3.9 | -4 | -4.1 | -4.1 | -4.3 | -4.4 | -4.5 | -4.6 | -4.8 | -5 | -5.2 | ||
| Adj Net Profit ⓘ | -0.1 | 0 | 0 | 0 | 0 | 0 | 0 | -0.1 | -0.1 | -0.1 | 0 | ||
| Cash Flow from Ops. ⓘ | -0.1 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.2 | - | ||
| Debt/CF from Ops. ⓘ | -43.6 | 17 | -65.8 | 370.5 | 24433.3 | 7705.3 | 1737.8 | -7238.4 | 7046.6 | 0 | - | ||
CAGR ⓘCAGR Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9 Years | 5 Years | 3 Years | 1 Years | |||||||||
| Sales ⓘ | NA | NA | NA | NA | ||||||||
| Adj EPS ⓘ | NA | NA | NA | NA | ||||||||
| BVPS ⓘ | 0 | 0 | 0 | 0 | ||||||||
| Share Price | -13.3% | -1.7% | 28.1% | 29.1% | ||||||||
Key Financial Parameters ⓘPerformance Ratio Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | TTM | ||
| Return on Equity % ⓘ | 3.1 | 1.4 | 1.1 | 1.3 | 1.9 | 2 | 1.7 | 2.9 | 3.4 | 3.9 | 6.3 | |
| Op. Profit Mgn % ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Net Profit Mgn % ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Debt to Equity ⓘ | -1.3 | -1.2 | -1.2 | -1.1 | -1.1 | -1.1 | -1 | -1 | -1.1 | 0 | - | |
| Working Cap Days ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cash Conv. Cycle ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Return on Equity has increased versus last 3 years average to 6.30%
Sales growth has been subdued in last 3 years 0.00%
Sales growth is not so good in last 4 quarters at 0.00%
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | -0.3 | - |
| TTM Sales (₹ Cr.) | 0 | - |
| BVPS (₹.) ⓘ | -5.2 | - |
| Reserves (₹ Cr.) ⓘ | -6 | - |
| P/BV ⓘ | -0.39 | - |
| PE ⓘ | 0.00 | - |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 1.49 / 2.04 |
| All Time Low / High (₹) | 0.92 / 46.90 |
| Market Cap (₹ Cr.) | 0.9 |
| Equity (₹ Cr.) | 4.3 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 36 |
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Raymed Labs was established in 1994 as a pharmaceutical company with emphasis on injectables with state of the art manufacturing facilities. the company is located at Dehradun Road, Saharanpur, UP. Manufacturing pharmaceutical products, as such, is a specialized job, however, manufacturing of injectables is even more difficult since they are normally given during a life saving situation thus their quality standards are much more stringent. Raymed’s quality quickly won the trusts of doctors and it established itself as one of the leading quality manufacturers of medicines in the area.
Raymed strives on a well organized management team of skilled and highly trained professionals from different streams. This team contains chemists, pharmacists, marketing professionals with in-depth knowledge & requirements for human and animal products.
Products range:
Download APP
